AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,177,000 | -30.0% | 244,920 | 0.0% | 2.18% | -13.3% |
Q1 2021 | $3,108,000 | +53.0% | 244,920 | +68.1% | 2.52% | +62.7% |
Q4 2020 | $2,031,000 | -48.5% | 145,715 | -35.5% | 1.55% | -43.9% |
Q2 2020 | $3,942,000 | +20.4% | 225,900 | 0.0% | 2.76% | -14.3% |
Q1 2020 | $3,273,000 | – | 225,900 | – | 3.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |